Skip to main content

Table 1 Inclusion and exclusion criteria for the diagnosis of MCI used in five studies

From: Using historical data to facilitate clinical prevention trials in Alzheimer disease? An analysis of longitudinal MCI (mild cognitive impairment) data sets

 

Eligibility

Inclusion

Exclusion

Age

MMSE

Other, medication

Functional impairment

Cognitive impairment

Depression

Other/vascular

ADNI

55–90

24–30

Stable medication, AChEIs, memantine admitted, 6 grades education or work history

No functional impairment, but many with high FAQ scores. CDR=0.5; memory ≥ 0.5

Memory complaint LogMem II, dependent on education

Geriatric Depression Scale ≥6

Hachinski Ischemic Score IS >5

NACC

--

--

Similar to ADNI

Essentially normal daily functions

Cognitive complaint, cognitive decline (clinician's diagnosis)

Not specified

Not specified

InDDEx

55–85

--

No AChEI in previous 2 weeks, no rivastigmine in previous 4 weeks

Cognitive symptoms (not specified); CDR=0.5

NYU delayed paragraph recall<9

HDRS>12, HDRS item1 > 1, DSM-IV major depression

AD criteria from DSM-IV or NINCDS-ADRDA mod. Hachinski Ischemic Score>4

CNG

≥ 50

≥ 20

A broader definition of MCI was used

Complaint of cognitive deficit in daily living; minor changes were tolerated: B-ADL< 4

Decline of cog. abilities (>1 SD) in at least one neuropsychological domain

Not specified

Not specified

BS-MC

N/A

N/A

Consecutively referred patients from GPs

Essentially Winblad et al. [26] criteria; no significant functional decline

Impairment (≤ −1.28 SD; age-, education-,and gender-adjusted) in ≥ one cognitive domain

Probable cause for MCI other than early AD, based on comprehensive medical exam and neuroimaging results

Not specified